SCHEMBL10749232

SCHEMBL10749232

O=[N+]([O-])c1ccc2ncccc2c1-n1[se]c2ccccc2c1=S

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NCOA1 Q15788 1/20 0.46
▸ NCOA3 Q9Y6Q9 1/20 0.46
▸ POLB P06746 2/20 0.46
▸ MAPT P10636 7/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ CTSB P07858 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916627 0.87 CYP1A2 (0.49) CYP1A2TSHRNCOA1NCOA3POLB
SCHEMBL10502218 0.81 CYP1A2 (0.47) CYP1A2NCOA1NCOA3POLBMAPT
SCHEMBL10501763 0.73 ALDH1A1 (0.44) CYP1A2TSHRPOLBMAPTALDH1A1
SCHEMBL10748399 0.72 CYP3A4 (0.39) POLBMAPTALDH1A1KDM4ELMNA
SCHEMBL10503512 0.71 ALDH1A1 (0.44) POLBMAPTALDH1A1KDM4ELMNA
SCHEMBL10748117 0.71 PIN1 (0.45) —
SCHEMBL10747422 0.70 MEN1 (0.41) TSHRPOLBMAPTALDH1A1SMN1; SMN2
SCHEMBL31067259 0.70 CYP1A2 (0.65) CYP1A2TSHRNCOA1NCOA3POLB
SCHEMBL5916849 0.69 LMNA (0.48) CYP1A2POLBMAPTALDH1A1SMN1; SMN2
SCHEMBL10747582 0.69 METAP2 (0.40) POLBMAPTALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback